EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study

R Dixon Dorand, Neil S Zheng, Rajiv Agarwal, Robert J Carroll, Samuel M Rubinstein, Karen M Winkfield, Wei-Qi Wei, Jordan Berlin, Xiao-Ou Shu iD

Cancers · 26.01.2023 · 15 (3) · 754

DOI: 10.3390/cancers15030754 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 26.01.2023. Verfasst von R Dixon Dorand und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 372…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemotherapy-induced peripheral neuropathy (CIPN) is a common therapeutic complication affecting cancer patients’ quality-of-life. We evaluated clinical characteristics, demographics, and lifestyle factors in association with CIPN following taxane treatment.

Methods

Data were extracted from the electronic health record of 3387 patients diagnosed with a primary cancer and receiving taxane (i.e., paclitaxel or docetaxel) at Vanderbilt University Medical Center. Neuropathy was assessed via a validated computer algorithm. Univariate and multivariate regression models were applied to evaluate odds ratios (ORs) and 95% confidence intervals (CIs) of CIPN-associated factors.

Results

Female sex (OR = 1.28, 95% CI = 1.01–1.62), high body-mass index (BMI) (OR = 1.31, 95% CI = 1.06–1.61 for overweight, and OR = 1.49, 95% CI = 1.21–1.83 for obesity), diabetes (OR = 1.66, 95% CI = 1.34–2.06), high mean taxane dose (OR = 1.05, 95% CI = 1.03–1.08 per 10 mg/m2), and more treatment cycles (1.12, 95% CI = 1.10–1.14) were positively associated with CIPN. Concurrent chemotherapy (OR = 0.74, 95% CI = 0.58–0.94) and concurrent radiotherapy (OR = 0.77, 95% CI = 0.59–1.00) were inversely associated with CIPN. Obesity and diabetes both had a stronger association with docetaxel CIPN compared to paclitaxel, although interaction was only significant for diabetes and taxane (p = 0.019). Increased BMI was associated with CIPN only among non-diabetic patients (OR:1.34 for overweight and 1.68 for obesity), while diabetes increased CIPN risk across all BMI strata (ORs were 2.65, 2.41, and 2.15 for normal weight, overweight, and obese, respectively) compared to normal-weight non-diabetic patients (p for interaction = 0.039).

Conclusions

Female sex, obesity, and diabetes are significantly associated with taxine-induced CIPN. Further research is needed to identify clinical and pharmacologic strategies to prevent and mitigate CIPN in at-risk patient populations.

Schlagwörter

Stichwörter der Autor:innen

chemotherapyperipheral neuropathytaxane

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37203, USA.
  • Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN 37203, USA.
  • Yale School of Medicine, Yale University, New Haven, CT 06510, USA.
  • Division of Hematology, Department of Medicine, Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, NC 27599, USA.
  • Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN 37203, USA.
  • Department of Medicine, Meharry Medical College, Nashville, TN 37208, USA.

ORCID-Profile: Xiao-Ou Shu

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Dorand, R. D., Zheng, N. S., Agarwal, R., Carroll, R. J., Rubinstein, S. M., Winkfield, K. M., Wei, W. Q., Berlin, J., & Shu, X. O. (2023). Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study. Cancers, 15(3), 754. https://doi.org/10.3390/cancers15030754

Vancouver

Dorand RD, Zheng NS, Agarwal R, Carroll RJ, Rubinstein SM, Winkfield KM, et al. Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study. Cancers. 2023;15(3):754. doi:10.3390/cancers15030754

BibTeX
@article{Dorand2023,
  author = {Dorand, R Dixon and Zheng, Neil S and Agarwal, Rajiv and Carroll, Robert J and Rubinstein, Samuel M and Winkfield, Karen M and Wei, Wei-Qi and Berlin, Jordan and Shu, Xiao-Ou},
  title = {Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {754},
  doi = {10.3390/cancers15030754}
}
Kostenlos starten →